Ligand profile
PMM
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03130 — Dihydropteroate synthase type-1
Identifiers
Database identifiers and provenance.
- Ligand ID
PMM- PDB
1eye- UniProt (similar protein)
P9WND1- Target protein
- KP13_03130
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 164.3
- −1 ≤ LogP ≤ 5 -1.10
- MW ≤ 500 Da 273.1
- LogP ≤ 5 -1.10
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 164.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1c(nc2c(n1)N=C(NC2=O)N)COP(=O)(O)Oc1c(nc2c(n1)N=C(NC2=O)N)COP(=O)(O)O
InChI=1S/C7H8N5O5P/c8-7-11-5-4(6(13)12-7)10-3(1-9-5)2-17-18(14,15)16/h1H,2H2,(H2,14,15,16)(H3,8,9,11,12,13)InChI=1S/C7H8N5O5P/c8-7-11-5-4(6(13)12-7)10-3(1-9-5)2-17-18(14,15)16/h1H,2H2,(H2,14,15,16)(H3,8,9,11,12,13)
AJXFJEHKGGCFNM-UHFFFAOYSA-NAJXFJEHKGGCFNM-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00809
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PMM →
- PDB RCSB structure 1eye →
- UniProt UniProt P9WND1 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PMM”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03130.
PDB 46
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 26
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).